Spiral Therapeutics
PrivateLast Round
Series B
Apr 14, 2026
Total Funding Raised
$32.6M
Momentum Score
25 /100
Company Overview
Spiral Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops therapies for inner ear disorders, such as hearing loss and balance disorders. The company's proprietary drug delivery platform, the Minimally Invasive Cochlear System (MICS™), is designed to provide minimally invasive, precise, and durable exposure of drugs to the cochlea. Spiral Therapeutics' lead program, SPT-2101, is a sustained-release steroid formulation for treating inner ear inflammation, specifically for patients with Meniere's Disease. The company is actively conducting clinical trials and raised a new round of financing in August 2023 to support the continued development of its therapeutic pipeline.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spiral Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Spiral Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 14, 2026 | ||||
| VC Round | Aug 30, 2023 | ||||
| VC Round | Jan 9, 2023 | ||||
| Series A | May 6, 2019 |
Spiral Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ferring Ventures SA | Series B, VC Round |
| Esperante Ventures | VC Round |
| Inveready | Series A |
| Savoir Capital | Series A, VC Round |
| Catalio Capital Management | VC Round |
| Humboldt Fund | VC Round |
| Camden Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
$27M round completed.
- Apr 1, 2026
Partnering with Advanced Bionics on cochlear implant innovation.
Spiral Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Spiral Therapeutics's valuation, stock price, and market status.
